prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype Basal, Final diagnosis. Breast, right, total mastectomy: Infiltrating ductal carcinoma, Nottingham grade III (of III), forming a 3.1 x 2.3. x. 2.1. cm. mass. in. the medial portion of the breast (AJCC pT2). Extensive angiolymphatic invasion is present. The surrounding breast parenchyma. shows proliferative fibrocystic changes characterized by sclerosing adenosis with associated calcifications. Nipple and skin are. without diagnostic abnormalities. All surgical resection margins including the deep margin, are negative for tumor (minimum. tumor. free. margin, 6 mm, deep margin). Skeletal muscle present and not involved by tumor. See comment. Lymph. nodes,. separately submitted right axillary No.1 and No.2, excision: A single (of 2) right axillary lymph node is positive. for micrometastatic (1 mm) carcinoma, present on frozen section only (AJCC pN1mi). Lymph nodes, right axillary, dissection: Multiple (7) right axillary lymph nodes are negative for tumor. Soft tissue, right axillary low region, excision: Fibroadipose tissue. No lymph node tissue or tumor identified. Comment: Estrogen: Focally positive, 1-10% nuclear staining. Progesterone: Negative, 0% nuclear staining. ER (Estrogen Receptor) test was developed and its performance characteristics determined by. It has not been cleared or approved by the U.S. Food and Drug Administration. HER2/neu protein overexpression is negative, score of 0, according to the interpretation guidelines in the FDA-approved. HercepTest.

expanded version (tokens=772) : 
 Histological classification: The final diagnosis of the breast pathology report is an infiltrating ductal carcinoma, Nottingham grade III.

Subtype: The subtype of this carcinoma is basal.

Necrosis: There is no mention of necrosis in the report.

Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

Histological grade: The histological grade of the carcinoma is a high-grade III out of III.

Nuclear grade: The report does not mention the nuclear grade.

Lymphovascular invasion: The report mentions extensive angiolymphatic invasion.

Calcification: The surrounding breast parenchyma shows proliferative fibrocystic changes characterized by sclerosing adenosis with associated calcifications.

Receptor status: The report provides information on the receptor status. Estrogen is focally positive, with 1-10% nuclear staining. Progesterone is negative, with 0% nuclear staining.

IHC and other ancillary testing results: The report indicates that HER2/neu protein overexpression is negative, with a score of 0, according to the interpretation guidelines in the FDA-approved HercepTest. The report also indicates that the ER (Estrogen Receptor) test was developed and its performance characteristics determined by, but it has not been cleared or approved by the U.S. Food and Drug Administration. 

Main points:

 - The breast pathology report reveals an infiltrating ductal carcinoma, Nottingham grade III (of III

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=915) : 
 The pathology report indicates a basal subtype infiltrating ductal carcinoma (Nottingham grade III) in the right breast. The tumor has angiolymphatic invasion with associated calcifications. Lymphovascular invasion is present, and a single of two axillary lymph nodes excised is positive for micrometastatic carcinoma. Estrogen receptor test shows 1-10% positivity, while progesterone receptor is negative. HER2/neu protein overexpression is negative.

